SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001513162-21-000056
Filing Date
2021-04-14
Accepted
2021-04-14 16:39:50
Documents
44
Period of Report
2021-02-28

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q form10q.htm 10-Q 766426
8 EXHIBIT 31.1 exhibit31_1.htm EX-31.1 8075
9 EXHIBIT 31.2 exhibit31_2.htm EX-31.2 8885
10 EXHIBIT 32.1 exhibit32_1.htm EX-32.1 4219
11 EXHIBIT 32.2 exhibit32_2.htm EX-32.2 4302
  Complete submission text file 0001513162-21-000056.txt   3454862

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE DOCUMENT bmra-20210228.xml EX-101.INS 588739
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bmra-20210228.xsd EX-101.SCH 28976
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bmra-20210228_cal.xml EX-101.CAL 33551
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bmra-20210228_def.xml EX-101.DEF 173076
6 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT bmra-20210228_lab.xml EX-101.LAB 282885
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bmra-20210228_pre.xml EX-101.PRE 178590
Mailing Address 17571 VON KARMAN AVENUE IRVINE CA 92614
Business Address 17571 VON KARMAN AVENUE IRVINE CA 92614 9496452111
BIOMERICA INC (Filer) CIK: 0000073290 (see all company filings)

IRS No.: 952645573 | State of Incorp.: DE | Fiscal Year End: 0531
Type: 10-Q | Act: 34 | File No.: 001-37863 | Film No.: 21826119
SIC: 2835 In Vitro & In Vivo Diagnostic Substances